Your new post is loading...
A new understanding of the immune system may be paving the way for the development of a vaccine for heart disease.
“If successful, a tolerogenic vaccine could stop the inflammation component of heart disease,” [Dr. Klaus] stated. “This could probably be used in conjunction with the statins (cholesterol-lowering drugs) that have already taken a significant chunk out of the numbers of people with heart disease. Together, they could deliver a nice one-two punch that could be important in further reducing heart disease.”
